Amersham Health and Corixa Corporation Announce Agreement to Develop and Market Bexxar in Europe for the Treatment of Non-Hodgkin's Lymphoma.
Business Wire › October 29, 2001
Linked as:
Extract
Amersham Health and Corixa Corporation Announce Agreement to Develop and Market Bexxar in Europe for the Treatment of Non-Hodgkin's Lymphoma.
Business Editors, Health/Medical Writers
BIOWIRE2K LONDON & SEATTLE--(BW HealthWire)--Oct. 29, 2001 Amersham Health (formerly Nycomed Amersham Imaging), the leader in medical diagnostic imaging and a major provider of radiotherapy products, and Corixa Corporation (Nasdaq:CRXA), a developer of immunotherapeutics, today announced that t...See the full content of this document
Sponsored links
